Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.

Neurology - 13 Jul 2004

Kang Jae H, Weuve Jennifer, Grodstein Francine

Abstract excerpt

BACKGROUND: A randomized trial of postmenopausal women over age 65 reported increased risks of cognitive decline with 4 years of combined estrogen and progestin treatment. However, questions remain, including the effect of longer duration or of hormone therapy initiated at younger ages. METHODS: The Nurses' Health Study is a prospective cohort begun in 1976, comprising 121,700 female nurses who report health...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Boston
Share to Cognition Disorders
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormone Replacement Therapy

Share to Neuropsychological Tests

Share to Postmenopause

Share to Progestins

Share to Socioeconomic Factors

Source

Identifiers

PMID: 15249618
DOI: 10.1212/01.wnl.0000132522.13574.67

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.PMID 15249618Read ↗

Cognitive function in nondemented older women who took estrogen after menopause.Semantic proximity Read ↗

Hormone replacement therapy and dementia risk among postmenopausal women: evidence from the UK BiobankSemantic proximity Read ↗

Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.Semantic proximity Read ↗

Female-specific factors are associated with cognition in the UK Biobank cohortSemantic proximity Read ↗

Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.Semantic proximity Read ↗

Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.Semantic proximity Read ↗

Apolipoprotein E, cardiovascular disease and cognitive function in aging women.Semantic proximity Read ↗

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.Semantic proximity Read ↗

Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.Semantic proximity Read ↗

Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.Semantic proximity Read ↗

Women’s brain aging: effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer’s diseaseSemantic proximity Read ↗

Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.